The abstract is read at the publisher; the summary is JClub's.
In Australian infants, replacing the first acellular pertussis dose with a whole-cell wP dose at ~6 weeks yields 6.4% vs 5.3% IgE-mediated food allergy by 12 months.
- Why it matters: Observational and mechanistic work suggested early switching from aP to wP might lower childhood IgE-mediated food allergy risk, but trial evidence was needed to guide policy.
- What they did: In a multicentre, participant- and outcome-assessor-blinded Bayesian adaptive randomized trial, infants received either an aP-only schedule or a mixed wP/aP schedule, with physician-confirmed food allergy at 12 months.
- The result: The posterior median difference for mixed wP/aP vs aP-only was 0.01 (-0.02, 0.04) with probability [<0] 0.25, and the trial stopped early for operational reasons.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.